Concepedia

Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea

Jeong Seong Yang, Kyung Jong Kim, Hongjo Choi, Seung Heon Lee

Annals of Laboratory Medicine · 2018 · 72 citations · 19 references

DOIFull text

Open access

Abstract

We determined the MICs of three anti-TB drugs for Korean MDR and XDR strains and identified various mutations in resistance-related genes. Further studies are needed to determine the genetic mechanisms underlying resistance to these drugs.

References

19

A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>

Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.1K citations · Full text

, , +18

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes

Gail L. Woods, Barbara A. Brown‐Elliott, Patricia S. Conville et al. · 2011 · 1.2K citations

, , +3

OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice

Makoto Matsumoto, Hiroyuki Hashizume, Tatsuo Tomishige et al. · PLoS Medicine · 2006 · 735 citations · Full text

Delamanid for Multidrug-Resistant Pulmonary Tuberculosis

Maria Tarcela Gler, Vija Skripconoka, Epifanio Sànchez-Garavito et al. · New England Journal of Medicine · 2012 · 731 citations · Full text

Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use Program

Mary C. Birmingham, Craig R. Rayner, Alison Meagher et al. · Clinical Infectious Diseases · 2003 · 426 citations

, , +19